Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation countermeasure

Cytokine

Volumn 62, Issue 2, 2013, Pages 278-285

  Kulkarni, Shilpa ^a   Singh, Pankaj K ^a   Ghosh, Sanchita P ^a   Posarac, Ana ^a   Singh, Vijay K ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

Author keywords

Gamma radiation; Gamma tocotrienol; Hematopoietic tissue; Mice; Radioprotection

Indexed keywords

COBALT 60; GAMMA TOCOTRIENOL; GRANULOCYTE COLONY STIMULATING FACTOR; NEUTRALIZING ANTIBODY; ALPHA TOCOPHEROL; ANTIBODY; CHROMAN DERIVATIVE; PLASTOCHROMANOL 8; RADIOPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; GAMMA RADIATION; HISTONE PHOSPHORYLATION; HISTOPATHOLOGY; IONIZING RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RADIATION INJURY; RADIATION PROTECTION; WHOLE BODY RADIATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; IMMUNOLOGY; RADIATION INJURIES;

MUS;

ANIMALS; ANTIBODIES; ANTIBODIES, NEUTRALIZING; CHROMANS; GRANULOCYTE COLONY-STIMULATING FACTOR; MALE; MICE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; VITAMIN E; WHOLE-BODY IRRADIATION;

EID: 84876801589     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.03.009     Document Type: Article

References (50)

1. Coleman C.N., Stone H.B., Moulder J.E., Pellmar T.C. Medicine. Modulation of radiation injury. Science. 2004, 304:693-694.
2. DiCarlo A.L., Hatchett R.J., Kaminski J.M., Ledney G.D., Pellmar T.C., Okunieff P., et al. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007. Radiat Res. 2008, 169:712-721.
3. Kulkarni S., Ghosh S.P., Hauer-Jensen M., Kumar K.S. Hematological targets of radiation damage. Curr Drug Targets. 2010, 11:1375-1385.
4. Mac Manus M., Lamborn K., Khan W., Varghese A., Graef L., Knox S. Radiotherapy-associated neutropenia and thrombocytopenia: analysis of risk factors and development of a predictive model. Blood. 1997, 89:2303-2310.
5. Xiao M., Whitnall M.H. Pharmacological countermeasures for the acute radiation syndrome. Curr Mol Pharmacol 2009, 2:122-133.
6. Singh V.K., Ducey E.J., Brown D.S., Whitnall M.H. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol. 2012, 88:296-310.
7. Ghosh S.P., Perkins M.W., Hieber K., Kulkarni S., Kao T.C., Reddy E.P., et al. Radiation protection by a new chemical entity, Ex-Rad: efficacy and mechanisms. Radiat Res. 2009, 171:173-179.
8. Delanian S., Baillet F., Huart J., Lefaix J.L., Maulard C., Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol. 1994, 32:12-20.
9. Vujaskovic Z., Batinic-Haberle I., Rabbani Z.N., Feng Q.F., Kang S.K., Spasojevic I., et al. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med. 2002, 33:857-863.
10. Blumenthal R.D., Sharkey R.M., Quinn L.M., Goldenberg D.M. Use of hematopoietic growth factors to control myelosuppression caused by radioimmunotherapy. Cancer Res. 1990, 50:1003s-1007s.
11. Basile L.A., Ellefson D., Gluzman-Poltorak Z., Junes-Gill K., Mar V., Mendonca S., et al. HemaMax, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primates. PLoS One. 2012, 7:e30434.
12. Ghosh S.P., Kulkarni S., Hieber K., Toles R., Romanyukha L., Kao T.C., et al. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Int J Radiat Biol. 2009, 85:598-606.
13. Kulkarni S., Ghosh S.P., Satyamitra M., Mog S., Hieber K., Romanyukha L., et al. Gamma-tocotrienol protects hematopoietic stem and progenitor cells in mice after total-body irradiation. Radiat Res. 2010, 173:738-747.
14. Berbee M., Fu Q., Garg S., Kulkarni S., Kumar K.S., Hauer-Jensen M. Pentoxifylline enhances the radioprotective properties of gamma-tocotrienol: differential effects on the hematopoietic, gastrointestinal and vascular systems. Radiat Res. 2011, 175:297-306.
15. MacVittie T.J., Farese A.M., Smith W.G., Baum C.M., Burton E., McKearn J.P. Myelopoietin, an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression. Blood. 2000, 95:837-845.
16. Singh V.K., Fatanmi O.O., Singh P.K., Whitnall M.H. Role of radiation-induced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation. Cytokine. 2012, 58:406-414.
17. Singh V.K., Christensen J., Fatanmi O.O., Gille D., Ducey E.J., Wise S.Y., et al. Myeloid Progenitors: a radiation countermeasure that is effective when initiated days after irradiation. Radiat Res. 2012, 177:781-791.
18. National Research Council of the National Academy of Sciences Guide for the Care and Use of Laboratory Animals 2011, National Academies Press, Washington, DC. 8th ed.
19. Montgomery C.A. Control of animal pain and distress in cancer and toxicologic research. J Am Vet Med Assoc. 1987, 191:1277-1281.
20. Tomasivic S.P., Coghlan L.G., Gray K.N., Mastromarino A.J., Travis E.L. IACUC evaluation of experiments requiring death as an end point: a cancer center's recommendations. Lab Animal. 1988, (January/February):31-34.
21. Singh P.K., Wise S.Y., Ducey E.J., Fatanmi O.O., Elliott T.B., Singh V.K. Alpha-tocopherol succinate protects mice against radiation-induced gastrointestinal injury. Radiat Res. 2012, 177:133-145.
22. ISO-ASTM Standard practice for use of an alanine dosimetry 2004, ISO/ASTM International Standard, p. 51607.
23. Nagy V. Accuracy considerations in EPR dosimetry. Appl Radiat Isot. 2000, 52:1039-1050.
24. Singh V.K., Brown D.S., Kao T.C. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int J Radiat Biol. 2010, 86:12-21.
25. Singh V.K., Ducey E.J., Fatanmi O.O., Singh P.K., Brown D.S., Purmal A., et al. CBLB613: A TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure. Radiat Res. 2012, 177:628-642.
26. Singh V.K., Parekh V.I., Brown D.S., Kao T.C., Mog S.R. Tocopherol succinate: modulation of antioxidant enzymes and oncogene expression, and hematopoietic recovery. Int J Radiat Oncol Biol Phys. 2011, 79:571-578.
27. Ho-Yen D.O., Slidders W. Bone marrow cellularity assessed by point-counting. J Clin Pathol. 1978, 31:753-756.
28. Singh P.K., Wise S.Y., Ducey E.J., Brown D.S., Singh V.K. Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine. 2011, 56:411-421.
29. Murphey R.D., Stern H.M., Straub C.T., Zon L.I. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des. 2006, 68:213-219.
30. Berbee M., Fu Q., Boerma M., Wang J., Kumar K.S., Hauer-Jensen M. Gamma-tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism. Radiat Res. 2009, 171:596-605.
31. Wilson A., Laurenti E., Oser G., van der Wath R.C., Blanco-Bose W., Jaworski M., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008, 135:1118-1129.
32. Broudy V.C., Lin N.L., Priestley G.V., Nocka K., Wolf N.S. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood. 1996, 88:75-81.
33. Schmidberger H., Hess C.F., Hoffmann W., Reuss-Borst M.A., Bamberg M. Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy. Eur J Cancer. 1993, 29A:1927-1931.
34. Pierelli L., Perillo A., Greggi S., Salerno G., Panici P.B., Menichella G., et al. Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. J Clin Oncol. 1999, 17:1288.
35. Farese A.M., Casey D.B., Smith W.G., Vigneulle R.M., McKearn J.P., MacVittie T.J. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration. Stem Cells. 2001, 19:522-533.
36. Shakhov A.N., Singh V.K., Bone F., Cheney A., Kononov Y., Krasnov P., et al. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLoS ONE. 2012, 7:e33044.
37. Krivokrysenko V.I., Shakhov A.N., Singh V.K., Bone F., Kononov Y., Shyshynova I., et al. Identification of Granulocyte Colony-Stimulating Factor and Interleukin-6 as Candidate Biomarkers of CBLB502 Efficacy as a Medical Radiation Countermeasure. J Pharmacol Exp Ther. 2012, 343:497-508.
38. Grace M.B., Singh V.K., Rhee J.G., Jackson W.E., Kao T.C., Whitnall M.H. 5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis. J Radiat Res. 2012, 53:840-853.
39. Klocke R., Kuhlmann M.T., Scobioala S., Schabitz W.R., Nikol S. Granulocyte colony-stimulating factor (G-CSF) for cardio- and cerebrovascular regenerative applications. Curr Med Chem. 2008, 15:968-977.
40. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005, 11:305-311.
41. Kuhlmann M.T., Kirchhof P., Klocke R., Hasib L., Stypmann J., Fabritz L., et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med. 2006, 203:87-97.
42. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005, 115:2083-2098.
43. Wadhwa M., Thorpe R. Haematopoietic growth factors and their therapeutic use. Thromb Haemost. 2008, 99:863-873.
44. Damon L.E. Mobilization of hematopoietic stem cells into the peripheral blood. Expert Rev Hematol. 2009, 2:717-733.
45. Luider J., Brown C., Selinger S., Quinlan D., Karlsson L., Ruether D., et al. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis. J Hematother. 1997, 6:575-580.
46. Jun H.S., Lee Y.M., Song K.D., Mansfield B.C., Chou J.Y. G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis. Blood. 2011, 117:3881-3892.
47. Kojima H., Otani A., Oishi A., Makiyama Y., Nakagawa S., Yoshimura N. Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphologic protective effect in oxygen-induced retinopathy. Blood. 2011, 117:1091-1100.
48. Tsai R.K., Chang C.H., Sheu M.M., Huang Z.L. Anti-apoptotic effects of human granulocyte colony-stimulating factor (G-CSF) on retinal ganglion cells after optic nerve crush are PI3K/AKT-dependent. Exp Eye Res. 2010, 90:537-545.
49. Herodin F., Roy L., Grenier N., Delaunay C., Bauge S., Vaurijoux A., et al. Antiapoptotic cytokines in combination with pegfilgrastim soon after irradiation mitigates myelosuppression in nonhuman primates exposed to high irradiation dose. Exp Hematol. 2007, 35:1172-1181.
50. Hayden M.S., Ghosh S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.